Sepax Technologies (赛分科技) announced on June 15, 2026, that its board of directors approved a proposal to invest approximately 300 million yuan (including land transfer fees, with actual investment amount subject to actual expenditure) to construct a scaled protein production and chromatography media capacity expansion project.
The project aims to comprehensively improve the company full-category chromatography media capacity layout, expand production scale, and enhance large-scale production and delivery capabilities to fully match growing market demand for chromatography media domestically and internationally. The scaled protein production base, once completed, will achieve large-scale supply of core raw materials, enabling the company to expand into biological macromolecule manufacturing and biopharmaceutical business segments.
Chromatography media are critical consumables used in biopharmaceutical downstream processing for protein purification. The investment reflects growing demand for bioprocessing capacity in China rapidly expanding biopharmaceutical industry.
